{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:22:52Z","timestamp":1793164972109,"version":"4.5.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Epstein-Barr virus (EBV) infects more than 90% of the global population and is etiologically linked to a wide spectrum of lymphoid and epithelial malignancies. Although its role as an oncogenic virus is well established, the mechanisms underlying EBV contribution to tumorigenesis remain undefined. This review revises the \u201chit-and-run\u201d hypothesis in EBV-associated cancers, proposing that the virus may initiate oncogenic transformation before leaving tumour cells. The review summarizes current evidence of EBV episomal loss, integration into host chromosomes, and the challenges associated with detecting traces of viral genetic material. Recent advances in highly sensitive detection methods, such as quantitative polymerase chain reaction (PCR), RNAscope, and single-cell droplet digital PCR, have revealed viral traces in lymphomas and carcinomas previously considered as EBV-negative by conventional\n                    <jats:italic>in situ<\/jats:italic>\n                    hybridization, supporting a broader role for EBV involvement in oncogenesis. Moreover, tumours with EBV traces have similar epigenetic and mutational landscapes to EBV-positive patients, suggesting that EBV-induced alterations may continue to have an impact even after EBV loss. Despite these findings, it still remains unclear whether residual viral elements contribute to ongoing oncogenic signalling, epigenetic alterations, or immune modulation within the tumour microenvironment. Investigating these factors could improve our ability to stratify patients based on EBV status, refine diagnostic criteria, and develop more targeted treatment approaches.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1742214","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:43:08Z","timestamp":1774370588000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Hit-and-run hypothesis: revisiting the impact of EBV in malignancies"],"prefix":"10.3389","volume":"17","author":[{"given":"Tamara","family":"Mangiaterra","sequence":"first","affiliation":[{"name":"Pathology Division, Multidisciplinary Institute for Investigation in Pediatric Pathologies (IMIPP-CONICET-GCBA), Ricardo Guti\u00e9rrez Children\u2019s Hospital","place":["Buenos Aires, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Chabay","sequence":"additional","affiliation":[{"name":"Pathology Division, Multidisciplinary Institute for Investigation in Pediatric Pathologies (IMIPP-CONICET-GCBA), Ricardo Guti\u00e9rrez Children\u2019s Hospital","place":["Buenos Aires, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Bellan","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Section of Pathology, University of Siena","place":["Siena, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Lazzi","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Section of Pathology, University of Siena","place":["Siena, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Onyango","sequence":"additional","affiliation":[{"name":"University of Nairobi","place":["Nairobi, Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, La Sapienza University","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Murray","sequence":"additional","affiliation":[{"name":"Limerick Digital Cancer Research Centre, Health Research Institute, Bernal Institute and School of Medicine, University of Limerick","place":["Limerick, Ireland"]},{"name":"Royal College of Surgeons Ireland (Bahrain)","place":["Busaiteen, Bahrain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Mundo","sequence":"additional","affiliation":[{"name":"Limerick Digital Cancer Research Centre, Health Research Institute, Bernal Institute and School of Medicine, University of Limerick","place":["Limerick, Ireland"]},{"name":"Department of Clinical and Molecular Medicine, La Sapienza University","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Anastasiadou","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, La Sapienza University","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"B1","article-title":"Virus particles in cultured lymphoblasts from burkitt\u2019s lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-319-22822-8_1","article-title":"Why and how epstein-barr virus was discovered 50 years ago","volume":"390","author":"Epstein","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B3","first-page":"1","article-title":"Epstein-barr virus and kaposi\u2019s sarcoma herpesvirus\/human herpesvirus 8","volume":"70","year":"1997","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"B4","article-title":"Epstein-Barr virus infection and human Malignancies","volume":"82","author":"Niedobitek","year":"2001","journal-title":"Int J Exp Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00265","article-title":"Epstein-barr virus-associated Malignancies: roles of viral oncoproteins in carcinogenesis","volume":"8","author":"El-Sharkawy","year":"2018","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2578","article-title":"Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes","volume":"17","author":"Saha","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e037505","DOI":"10.1136\/bmjopen-2020-037505","article-title":"Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable Malignancies, 1990-2017","volume":"10","author":"Khan","year":"2020","journal-title":"BMJ Open"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2000.0783","article-title":"Biology and disease associations of Epstein-Barr virus","volume":"356","author":"Crawford","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03692-w","article-title":"T and B\u2009cell responses against Epstein-Barr virus in primary sclerosing cholangitis","volume":"31","author":"ElAbd","year":"2025","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: Biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2519703","article-title":"Gastrointestinal inflammation and cancer: viral and bacterial interplay","volume":"17","author":"Arr\u00e8","year":"2025","journal-title":"Gut Microbes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of Epstein-Barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","article-title":"Infectious mononucleosis","volume":"362","author":"Luzuriaga","year":"2010","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399404008440","article-title":"Infectious mononucleosis and Epstein-Barr virus","volume":"6","author":"Vetsika","year":"2004","journal-title":"Expert Rev Mol Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/MOH.0b013e32834daa08","article-title":"Current diagnosis and management of infectious mononucleosis","volume":"19","author":"Vouloumanou","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire","year":"2018","journal-title":"J Clin Virol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005286","article-title":"The incubation period of primary epstein-barr virus infection: viral dynamics and immunologic events","volume":"11","author":"Dunmire","year":"2015","journal-title":"PloS Pathog"},{"key":"B18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-319-22822-8_8","article-title":"EBV persistence--introducing the virus","volume":"390","author":"Thorley-Lawson","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3390\/v15030714","article-title":"Epstein-barr virus history and pathogenesis","volume":"15","author":"Yu","year":"2023","journal-title":"Viruses"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00238-19","article-title":"Mechanisms of B-cell oncogenesis induced by epstein-barr virus","volume":"93","author":"Saha","year":"2019","journal-title":"J Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.14.6324-6332.2000","article-title":"Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells","volume":"74","author":"Molesworth","year":"2000","journal-title":"J Virol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09166-w","article-title":"R9AP is a common receptor for EBV infection in epithelial cells and B cells","volume":"630","author":"Li","year":"2025","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.3390\/v13122344","article-title":"Molecular basis of epstein-barr virus latency establishment and lytic reactivation","volume":"13","author":"Murata","year":"2021","journal-title":"Viruses"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-022-03414-4","article-title":"New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders","volume":"482","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.4.1477","article-title":"Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells","volume":"72","author":"Adams","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"a013029","DOI":"10.1101\/cshperspect.a013029","article-title":"Replication of Epstein-Barr viral DNA","volume":"5","author":"Hammerschmidt","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1743-422X-6-29","article-title":"Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats","volume":"6","author":"Aiyar","year":"2009","journal-title":"Virol J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.4.1865","article-title":"Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1","volume":"98","author":"Hung","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.5.8.1822-1832.1985","article-title":"A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components","volume":"5","author":"Reisman","year":"1985","journal-title":"Mol Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01606-13","article-title":"Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes","volume":"87","author":"Hodin","year":"2013","journal-title":"J Virol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2011.02098.x","article-title":"DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization","volume":"102","author":"Yasuda","year":"2011","journal-title":"Cancer Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1097-2765(02)00476-8","article-title":"Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication","volume":"9","author":"Deng","year":"2002","journal-title":"Mol Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.5.2.410","article-title":"A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus","volume":"5","author":"Sugden","year":"1985","journal-title":"Mol Cell Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.9.6069-6073.1994","article-title":"Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt\u2019s lymphoma (BL) line Akata: Malignant phenotypes of BL cells are dependent on EBV","volume":"68","author":"Shimizu","year":"1994","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.3.1292-1299.1993","article-title":"Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines","volume":"67","author":"Delecluse","year":"1993","journal-title":"J Virol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910560207","article-title":"Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis","volume":"56","author":"Kripalani-Joshi","year":"1994","journal-title":"Int J Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9440(10)64697-4","article-title":"Gammaherpesviruses and \u2018Hit-and-run\u2019 oncogenesis","volume":"156","author":"Ambinder","year":"2000","journal-title":"Am J Pathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605985103","article-title":"Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV\u2019s transforming genes","volume":"103","author":"Altmann","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23685","article-title":"Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma","volume":"123","author":"Dittmer","year":"2008","journal-title":"Int J Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63184-7","article-title":"Integration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expression","volume":"164","author":"Takakuwa","year":"2004","journal-title":"Am J Pathol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7150\/jca.13150","article-title":"Genome-wide analysis of epstein-barr virus (EBV) integration and strain in C666\u20131 and raji cells","volume":"7","author":"Xiao","year":"2016","journal-title":"J Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(76)90331-4","article-title":"Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line","volume":"102","author":"Lindahl","year":"1976","journal-title":"J Mol Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/gcc.2870080108","article-title":"Non-random integration of Epstein-Barr virus in lymphoblastoid cell lines","volume":"8","author":"Lestou","year":"1993","journal-title":"Genes Chromosomes Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700152","article-title":"Epstein-Barr virus is integrated between REL and BCL-11A in American Burkitt lymphoma cell line (NAB-2)","volume":"84","author":"Luo","year":"2004","journal-title":"Lab Invest"},{"key":"B45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/v14010086","article-title":"Non-random pattern of integration for epstein-barr virus with preference for gene-poor genomic chromosomal regions into the genome of burkitt lymphoma cell lines","volume":"14","author":"Janjetovic","year":"2022","journal-title":"Viruses"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01169-10","article-title":"Herpesviruses and chromosomal integration","volume":"84","author":"Morissette","year":"2010","journal-title":"J Virol"},{"key":"B47","article-title":"Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a \u2018hit and run\u2019 mechanism","volume":"57","author":"Skinner","year":"1976","journal-title":"Br J Exp Pathol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.7.3089-3094.2001","article-title":"\u2018Hit-and-run\u2019 transformation by adenovirus oncogenes","volume":"75","author":"Nevels","year":"2001","journal-title":"J Virol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"188476","DOI":"10.1016\/j.bbcan.2020.188476","article-title":"A \u2018hit-and-run\u2019 affair - A possible link for cancer progression in virally driven cancers","volume":"1875","author":"Ferreira","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coviro.2018.09.003","article-title":"More than just oncogenes: mechanisms of tumorigenesis by human viruses","volume":"32","author":"Gaglia","year":"2018","journal-title":"Curr Opin Virol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34623","article-title":"Presence of EBV antigens detected by a sensitive method in pediatric and adult Diffuse Large B-cell lymphomas","volume":"153","author":"Mangiaterra","year":"2023","journal-title":"Int J Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2010.08.007","article-title":"Viral hit and run-oncogenesis: genetic and epigenetic scenarios","volume":"305","author":"Niller","year":"2011","journal-title":"Cancer Lett"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2016.08.08","article-title":"Immunohistochemistry for pathologists: protocols, pitfalls, and tips","volume":"50","author":"Kim","year":"2016","journal-title":"J Pathol Transl Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/pathogens9030226","article-title":"Recent advances in diagnostic approaches for epstein-barr virus","volume":"9","author":"AbuSalah","year":"2020","journal-title":"Pathogens"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-014-0209-0","article-title":"Detection of EBV in reactive and neoplastic lymphoproliferations in adults-when and how","volume":"7","author":"Stuhlmann-Laeisz","year":"2014","journal-title":"J Hematop"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-0575-3","article-title":"Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas","volume":"33","author":"Mundo","year":"2020","journal-title":"Mod Pathol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/v15051060","article-title":"Recombinant virus quantification using single-cell droplet digital PCR: a method for infectious titer quantification","volume":"15","author":"Korotkaja","year":"2023","journal-title":"Viruses"},{"key":"B58","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1038\/s41467-019-11531-z","article-title":"Ultra-sensitive digital quantification of proteins and mRNA in single cells","volume":"10","author":"Lin","year":"2019","journal-title":"Nat Commun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10979","article-title":"Hodgkin lymphoma and Epstein-Barr virus (EBV): no evidence to support hit-and-run mechanism in cases classified as non-EBV-associated","volume":"104","author":"Gallagher","year":"2003","journal-title":"Int J Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0558-9","article-title":"The landscape of viral associations in human cancers","volume":"52","author":"Zapatka","year":"2020","journal-title":"Nat Genet"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00229","article-title":"Unveiling another missing piece in EBV-driven lymphomagenesis: EBV-encoded microRNAs expression in EBER-negative burkitt lymphoma cases","volume":"8","author":"Mundo","year":"2017","journal-title":"Front Microbiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00262-023-03617-x","article-title":"Presence of Epstein-Barr virus (EBV) antigens detected by sensitive methods has no influence on local immune environment in diffuse large B cell lymphoma","volume":"73","author":"Mangiaterra","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13027-022-00469-5","article-title":"EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negative","volume":"17","author":"Siciliano","year":"2022","journal-title":"Infect Agent Cancer"},{"key":"B64","doi-asserted-by":"publisher","first-page":"10813","DOI":"10.1038\/s41598-017-11052-z","article-title":"Cytotoxic response against Epstein Barr virus coexists with diffuse large B-cell lymphoma tolerogenic microenvironment: clinical features and survival impact","volume":"7","author":"Cohen","year":"2017","journal-title":"Sci Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0178-x","article-title":"Epstein\u2013Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas","volume":"33","author":"Anastasiadou","year":"2019","journal-title":"Leukemia"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021346","article-title":"Epstein-Barr virus-encoded EBNA2 downregulates ICOSL by inducing miR-24 in B-cell lymphoma","volume":"143","author":"Leopizzi","year":"2024","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-020-00792-2","article-title":"Epigenetic lifestyle of Epstein-Barr virus","volume":"42","author":"Buschle","year":"2020","journal-title":"Semin Immunopathol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/path.6067","article-title":"Loss of viral genome with altered immune microenvironment during tumour progression of Epstein-Barr virus-associated gastric carcinoma","volume":"260","author":"Kondo","year":"2023","journal-title":"J Pathol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1742214\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:43:10Z","timestamp":1774370590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1742214\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2026.1742214"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1742214","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"article-number":"1742214"}}